Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration

E-ISSN： 1873-4294|15|21|2116-2138

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.15, Iss.21, 2015-01, pp. : 2116-2138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Application of Biliverdin Reductase and its Fragments to Modulate insulin/IGF-1/MAPK/PI3-K Signaling Pathways in Therapeutic Settings

Current Drug Targets, Vol. 11, Iss. 12, 2010-12 ,pp. : 1586-1594

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting mTOR Pathways in Human Malignancies

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2766-2777

Bentham Science Publishers

Access to resources Recommend Favorite

Sirtuins: Common Targets in Aging and in Neurodegeneration

Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. : 1270-1280

Bentham Science Publishers

Access to resources Recommend Favorite

IGF-1 receptor and longevity in mice

Reproductive BioMedicine Online, Vol. 6, Iss. 2, 2003-03 ,pp. : 243-243

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 651-660

Bentham Science Publishers

Access to resources Recommend Favorite